Search Results 1571-1580 of 18745 for Activation

  1. Ciltacabtagene autoleucel (intravenous route) - Side effects & uses - Mayo Clinic

    This medicine may cause a severe inflammatory condition that could be life-threatening, including hemophagocytic lymphohistiocytosis/macrophage activation ...

  2. Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma - Mayo Clinic

    Activated B-cell-like (ABC) diffuse large B-cell lymphoma (DLBCL), the major constituent of nongerminal center B-cell-like (non-GCB) DLBCL, is associated ...

  3. Publications - J Christopher Ray, M.D. - Mayo Clinic

    Macrophage Activation Led Acute Heart Failure Managed Successfully with Immunosuppression. J Blood Med. 2021; 12:1037-1043 Epub 2021 Dec 07. View PubMed ...

  4. CAST-AI: Cystectomy after systemic therapy with ADC and Immunotherapy - Mayo Clinic

    Prothrombin time (PT)/international normalized ratio (INR)/activated partial thromboplastin time (aPTT) ≤ 1.5 x ULN or if patient is receiving ...

  5. Mayo Clinic Proceedings: In the Limelight, January 2022

    ... activated” endothelial phenotype. Such endothelial abnormalities may be further exacerbated by the hemodynamic stress imposed by the systemic and regional ...

  6. Publications - Leslie J. Donato, Ph.D. - Mayo Clinic

    Relation of Activated Clotting Times During Percutaneous Coronary Intervention to Outcomes. Am J Cardiol. 2016 Mar 1; 117 (5):703-8 Epub 2015 Dec 13. View ...

  7. What has changed in the national field triage guidelines and what it means for you - Mayo Clinic

    Mhayamaguru says the new guidelines will not heavily affect trauma team activation (TTA) criteria, though they may point to missing TTA elements. "Mostly ...

  8. A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML) - Mayo Clinic

    Participant has presence of the FLT3/ITD activating mutation in the BM or PB as determined by the local institution at diagnosis. Participant must meet the ...

  9. Publications - Aniket A. Saoji, Ph.D. - Mayo Clinic

    Does early activation within hours after cochlear implant surgery influence electrode impedances? Int J Audiol. 2022 Jun; 61 (6):520-525 Epub 2021 July 18

  10. Cancer Clinical Trials - Medical Professionals

    We present here a CAR design that allows PD-1 to recognize PD-L1 on the tumor; however, the intracellular CAR design is one that results in T cell activation as ...